TikTok, X, and Instagram are flooded with videos about a mysterious “2025 throat virus” that’s making everyone sick. The ...

Sanofi (NASDAQ:SNY) is one of the Cheap NASDAQ Stocks to Buy Now. On December 4, Sanofi (NASDAQ:SNY) announced the completion ...

Paris: French multinational pharmaceutical giant, Sanofi, has announced the completion of its acquisition of Vicebio Ltd.This ...

Flu Statistics: The CDC reports that the 2025 Southern Hemisphere seasonal influenza vaccine reduced influenza-associated hospitalizations by nearly 50%. Thousands of deaths in the U.S. each year are ...

Innovative nanoparticle vaccines show promise in triggering broad immune responses against deadly filoviruses. Rational design of next-generation filovirus vaccines combining glycoprotein ...

Sanofi (NASDAQ:SNY) is one of the best pharma stocks to invest in. Sanofi (NASDAQ:SNY) was downgraded to Neutral from ...

Sanofi, an R&D driven, AI-powered biopharma company, announces the completion of its acquisition of Vicebio Ltd (Vicebio). This acquisition brings an early-stage combination vaccine candidate for ...

O 3, Michael Kantrowitz, Chief Investment Strategist at Piper Sandler, appeared on CNBC television to discuss the market ...

Sanofi completes acquisition of VicebioParis, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”).

We used Finviz to compile a list of the best pharma stocks and selected the top 11 with the highest number of hedge fund ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if this is right time to buy.